Cipla Q3 Results: Net profit rises 10% but fails to keep up with analysts' estimates
Cipla Q3 Results: The drug maker reported a 9.9 per cent year-on-year increase in net profit to Rs 801 crore for the October-December period and revenue growth of six per cent to Rs 5,810.1 crore — both missing analysts' estimates. Cipla shares extended their intraday losses after the earnings announcement.
Cipla on Wednesday reported a net profit of Rs 801 crore for the October-December period, an increase of 9.9 per cent compared with the corresponding period a year ago. The Mumbai-based drug maker's revenue grew six per cent on a year-on-year basis to Rs 5,810.1 crore, according to a regulatory filing.
Both topline and bottomline fell short of analysts' estimates.
According to Zee Business research, the drug maker's quarterly net profit was estimated at Rs 914 crore and revenue at Rs 6,168 crore.
The pharmaceutical major's EBITDA margin — a key measure of a business's profitability — improved by 190 bps on a quarter-on-quarter basis and 150 bps on a year-on-year basis to 24.2 per cent, in line with analyst expectations.
The company's quarterly margin was estimated at 24 per cent, according to Zee Business research.
"Our performance reflects sustained momentum in core One-India and US businesses driving our overall revenue growth of six per cent reported and 11 per cent on a ex-COVID basis. Our One-India franchise delivered strong performance across therapies and segments with double-digit market beating growth in prescription on a COVID-adjusted base," said Umang Vohra,
MD and global CEO, Cipla.
Revenue from the North America market reached its highest level in a quarter, to $195 million, driven by the contribution of differentiated products and market share expansion in flagship respiratory and peptide franchises, he said.
The Cipla stock declined by Rs 22.5 or 2.1 per cent to end at Rs 1,039 apiece on BSE after the earnings announcement amid overall weakness in the market.
Cipla shares lost 3.6 per cent of their value in the quarter ended December 2022, a period in which the Sensex benchmark rose 5.9 per cent.
Catch LIVE stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
03:39 PM IST